Balancing Efficacy and Safety of an Anti-DLL4 Antibody through Pharmacokinetic Modulation - PubMed (original) (raw)

. 2016 Mar 15;22(6):1469-79.

doi: 10.1158/1078-0432.CCR-15-1380. Epub 2015 Nov 20.

Gu Zhang 2, Joseph C Beyer 1, Christina L Zuch de Zafra 1, Priyanka Gupta 1, Amrita V Kamath 1, Nicholas Lewin-Koh 3, Jacqueline Tarrant 1, Krishna P Allamneni 1, Gary Cain 1, Sharon Yee 4, Sarajane Ross 4, Ryan Cook 5, Siao Ping Tsai 5, Jane Ruppel 1, John Brady Ridgway 2, Maciej Paluch 6, Philip E Hass 6, Jayme Franklin 7, Minhong Yan 8

Affiliations

Balancing Efficacy and Safety of an Anti-DLL4 Antibody through Pharmacokinetic Modulation

Jessica A Couch et al. Clin Cancer Res. 2016.

Abstract

Purpose: Although agents targeting Delta-like ligand 4 (DLL4) have shown great promise for angiogenesis-based cancer therapy, findings in recent studies have raised serious safety concerns. To further evaluate the potential for therapeutic targeting of the DLL4 pathway, we pursued a novel strategy to reduce toxicities related to DLL4 inhibition by modulating the pharmacokinetic (PK) properties of an anti-DLL4 antibody.

Experimental design: The F(ab')2 fragment of anti-DLL4 antibody (anti-DLL4 F(ab')2) was generated and assessed in efficacy and toxicity studies.

Results: Anti-DLL4 F(ab')2 enables greater control over the extent and duration of DLL4 inhibition, such that intermittent dosing of anti-DLL4 F(ab')2 can maintain significant antitumor activity while markedly mitigating known toxicities associated with continuous pathway inhibition.

Conclusions: PK modulation has potentially broad implications for development of antibody-based therapeutics. Our safety studies with anti-DLL4 F(ab')2 also provide new evidence reinforcing the notion that the DLL4 pathway is extremely sensitive to pharmacologic perturbation, further underscoring the importance of exercising caution to safely harness this potent pathway in humans.

©2015 American Association for Cancer Research.

PubMed Disclaimer

MeSH terms

Substances

LinkOut - more resources